Skip to main content
Erschienen in: Comparative Clinical Pathology 1/2016

01.01.2016 | Original Article

RETRACTED ARTICLE: Prevalence of the C282Y and H63D mutations of the HFE hemochromatosis gene in Azerian major β-thalassemia and iron overload

verfasst von: Abolhassan Ghaderi, Mohammad Reza Hafezi Ahmadi, Ehsan Hosseini, Ali Akbar Movasaghpour Akbari, Abbas Ali Hosein Pour Feyzi, Ataollah Hiradfar, Majid Farshdousti Hagh

Erschienen in: Comparative Clinical Pathology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

In this study, we have determined the allele frequency of HFE mutations H63D and C282Y in a group of Azerian beta-thalassemia major patients. These two mutations are implicated in hereditary hemochromatosis among Caucasians. In this study, we wanted to outbreak these mutations with the iron status in major beta-thalassemia patients. Sixty Azerian major beta-thalassemias were screening for the C282Y and H63D by digestion of polymerase chain reaction products (PCRP). Serum ferritin level was measured by enzyme-linked immunosorbent assay (ELISA). The allele frequency of H63D mutation was 20 %. C282Y mutation was not present in our studied patients. No statistically significant difference of serum ferritin level was found between major beta-thalassemia with and without HFE mutations. Our data suggest that H63D mutation is so frequent in Azerian major beta-thalassemia patients than in the general population and that the coinheritance of H63D mutation does not influence the severity of iron overload in these patients.
Literatur
Zurück zum Zitat Arab A, Karimipoor M, Rajabi A, Hamid M, Arjmandi S, Zeinali S (2011) Molecular characterization of beta-thalassemia intermedia: a report from Iran. Mol Biol Rep 38(7):4321–6CrossRefPubMed Arab A, Karimipoor M, Rajabi A, Hamid M, Arjmandi S, Zeinali S (2011) Molecular characterization of beta-thalassemia intermedia: a report from Iran. Mol Biol Rep 38(7):4321–6CrossRefPubMed
Zurück zum Zitat Borgna-Pignatti C, Solinas A, Bombieri C, Micciolo R, Gamberini MR, De Stefano P (1998) The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated. Br J Haematol 103(3):813–6CrossRefPubMed Borgna-Pignatti C, Solinas A, Bombieri C, Micciolo R, Gamberini MR, De Stefano P (1998) The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated. Br J Haematol 103(3):813–6CrossRefPubMed
Zurück zum Zitat Dhillon BK, Prakash S, Chandak GR, Chawla YK, Das R (2012) H63D mutation in HFE gene is common in Indians and is associated with the european haplotype. J Genet 91(2):229–32CrossRefPubMed Dhillon BK, Prakash S, Chandak GR, Chawla YK, Das R (2012) H63D mutation in HFE gene is common in Indians and is associated with the european haplotype. J Genet 91(2):229–32CrossRefPubMed
Zurück zum Zitat Elmrghni S, Dixon RA, Williams DR (2011) Frequencies of HFE gene mutations associated with haemochromatosis in the population of Libya living in Benghazi. Int J Clin Exp Med 4(3):200–4PubMedPubMedCentral Elmrghni S, Dixon RA, Williams DR (2011) Frequencies of HFE gene mutations associated with haemochromatosis in the population of Libya living in Benghazi. Int J Clin Exp Med 4(3):200–4PubMedPubMedCentral
Zurück zum Zitat Farajnia S, Nakhlband A, Rafeey M, Sakha K (2010) Early age onset familial Mediterranean fever associated with compound heterozygote M680I/M694V mutation. Afr J Biotechnol 5(19):34–37 Farajnia S, Nakhlband A, Rafeey M, Sakha K (2010) Early age onset familial Mediterranean fever associated with compound heterozygote M680I/M694V mutation. Afr J Biotechnol 5(19):34–37
Zurück zum Zitat Feder JN, Gnirke A, Thomas W (1996) A novel MHC class i like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408CrossRefPubMed Feder JN, Gnirke A, Thomas W (1996) A novel MHC class i like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408CrossRefPubMed
Zurück zum Zitat Feder J, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC (1997) The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 272:14025–8CrossRefPubMed Feder J, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC (1997) The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 272:14025–8CrossRefPubMed
Zurück zum Zitat Galanello R, Origa R (2011) Beta-thalassemia. Orphanet J Rare Dis 5:11CrossRef Galanello R, Origa R (2011) Beta-thalassemia. Orphanet J Rare Dis 5:11CrossRef
Zurück zum Zitat Habibzadeh F, Yadollahie M, Merat A, Haghshenas M (1998) Thalassemia in Iran; an overview. Arch Iran Med 1(1):27–33 Habibzadeh F, Yadollahie M, Merat A, Haghshenas M (1998) Thalassemia in Iran; an overview. Arch Iran Med 1(1):27–33
Zurück zum Zitat Hanson EH, Imperatore G, Burke W (2001) HFE gene and hereditary hemochromatosis: a HuGE review. Human genome epidemiology. Am J Epidemiol 154(3):193–206CrossRefPubMed Hanson EH, Imperatore G, Burke W (2001) HFE gene and hereditary hemochromatosis: a HuGE review. Human genome epidemiology. Am J Epidemiol 154(3):193–206CrossRefPubMed
Zurück zum Zitat Longo F, Zecchina G, Sbaiz L, Fischer R, Piga A, Camaschella C (1999) The influence of hemochromatosis mutations on iron overload of thalassemia major. Haematologica 84(9):799–803PubMed Longo F, Zecchina G, Sbaiz L, Fischer R, Piga A, Camaschella C (1999) The influence of hemochromatosis mutations on iron overload of thalassemia major. Haematologica 84(9):799–803PubMed
Zurück zum Zitat Madani HA, Afify RA, Abd El-Aal AA, Salama N, Ramy N (2011) Role of HFE gene mutations on developing iron overload in beta-thalassaemia carriers in Egypt. East Mediterr Health J = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 17(6):546–51 Madani HA, Afify RA, Abd El-Aal AA, Salama N, Ramy N (2011) Role of HFE gene mutations on developing iron overload in beta-thalassaemia carriers in Egypt. East Mediterr Health J = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 17(6):546–51
Zurück zum Zitat Melchiori L, Gardenghi S, Rivella S (2010) Beta-thalassemia: HiJAKing ineffective erythropoiesis and iron overload. Adv Hematol 210:638–640 Melchiori L, Gardenghi S, Rivella S (2010) Beta-thalassemia: HiJAKing ineffective erythropoiesis and iron overload. Adv Hematol 210:638–640
Zurück zum Zitat Melis MA, Cau M, Deidda F, Barella S, Cao A, Galanello R (2002) H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers. Haematologica 87(3):242–5PubMed Melis MA, Cau M, Deidda F, Barella S, Cao A, Galanello R (2002) H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers. Haematologica 87(3):242–5PubMed
Zurück zum Zitat Mellouli F, El Borgi W, Kaabi H, Ben Hassen E, Sassi R, Hmida H (2006) HFE gene mutations in Tunisian major beta-thalassemia and iron overload. Transfus Clin Biol J Soc Fr Transfus Sanguine 13(6):353–7CrossRef Mellouli F, El Borgi W, Kaabi H, Ben Hassen E, Sassi R, Hmida H (2006) HFE gene mutations in Tunisian major beta-thalassemia and iron overload. Transfus Clin Biol J Soc Fr Transfus Sanguine 13(6):353–7CrossRef
Zurück zum Zitat Oliveira TM, Souza FP, Jardim AC, Cordeiro JA, Pinho JR, Sitnik R (2006) HFE gene mutations in Brazilian thalassemic patients. Braz J of Med Biol Res = Rev Bras Pesqui Med Biol / Soc Bras Bio 39(12):1575–80 Oliveira TM, Souza FP, Jardim AC, Cordeiro JA, Pinho JR, Sitnik R (2006) HFE gene mutations in Brazilian thalassemic patients. Braz J of Med Biol Res = Rev Bras Pesqui Med Biol / Soc Bras Bio 39(12):1575–80
Zurück zum Zitat Pietrangelo A (2002) Physiology of iron transport and the hemochromatosis gene. Am J Physiol Gastrointest Liver physiol 282(3):G403–14CrossRefPubMed Pietrangelo A (2002) Physiology of iron transport and the hemochromatosis gene. Am J Physiol Gastrointest Liver physiol 282(3):G403–14CrossRefPubMed
Zurück zum Zitat Pietrangelo A (2004) Hereditary hemochromatosis—a new look at an old disease. N Engl J Med 350(23):2383–97CrossRefPubMed Pietrangelo A (2004) Hereditary hemochromatosis—a new look at an old disease. N Engl J Med 350(23):2383–97CrossRefPubMed
Zurück zum Zitat Pietrangelo A (2010) Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 139(2):393–408CrossRefPubMed Pietrangelo A (2010) Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 139(2):393–408CrossRefPubMed
Zurück zum Zitat Piperno A, Arosio C, Fossati L, Vigano M, Trombini P, Vergani A (2000) Two novel nonsense mutations of HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology 119:441–5CrossRefPubMed Piperno A, Arosio C, Fossati L, Vigano M, Trombini P, Vergani A (2000) Two novel nonsense mutations of HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology 119:441–5CrossRefPubMed
Zurück zum Zitat Rees DC, Luo LY, Thein SL, Singh BM, Wickramasinghe S (1997) Nontransfusional iron overload in thalassemia: association with hereditary hemochromatosis. Blood 90(8):3234–6PubMed Rees DC, Luo LY, Thein SL, Singh BM, Wickramasinghe S (1997) Nontransfusional iron overload in thalassemia: association with hereditary hemochromatosis. Blood 90(8):3234–6PubMed
Zurück zum Zitat Rees DC, Singh BM, Luo LY, Wickramasinghe S, Thein SL (1998) Nontransfusional iron overload in thalassemia. Association with hereditary hemochromatosis. Ann N Y Acad Sci 850:490–4CrossRefPubMed Rees DC, Singh BM, Luo LY, Wickramasinghe S, Thein SL (1998) Nontransfusional iron overload in thalassemia. Association with hereditary hemochromatosis. Ann N Y Acad Sci 850:490–4CrossRefPubMed
Zurück zum Zitat Ribeil JA, Arlet JB, Dussiot M, Moura IC, Courtois G, Hermine O (2013) Ineffective erythropoiesis in beta-thalassemia. Sci World J 213:394–397 Ribeil JA, Arlet JB, Dussiot M, Moura IC, Courtois G, Hermine O (2013) Ineffective erythropoiesis in beta-thalassemia. Sci World J 213:394–397
Zurück zum Zitat Santos PC, Cancado RD, Terada CT, Rostelato S, Gonzales I, Hirata RD (2010) HFE gene mutations and iron status of Brazilian blood donors. Braz J Med Biol Res = Rev Bras Pesqui Med Biol / Soc Bras Bio 43(1):107–14 Santos PC, Cancado RD, Terada CT, Rostelato S, Gonzales I, Hirata RD (2010) HFE gene mutations and iron status of Brazilian blood donors. Braz J Med Biol Res = Rev Bras Pesqui Med Biol / Soc Bras Bio 43(1):107–14
Zurück zum Zitat Teimourian S, Khatibi T, Pourfarzad F, Jalil-Nejad S, Azad M (2001) Amplification Refractory mutation system (ARMS) and reverse hybridization n in the detection of beta-thalassemia mutations. Arch Iran Med 4(4):165 Teimourian S, Khatibi T, Pourfarzad F, Jalil-Nejad S, Azad M (2001) Amplification Refractory mutation system (ARMS) and reverse hybridization n in the detection of beta-thalassemia mutations. Arch Iran Med 4(4):165
Metadaten
Titel
RETRACTED ARTICLE: Prevalence of the C282Y and H63D mutations of the HFE hemochromatosis gene in Azerian major β-thalassemia and iron overload
verfasst von
Abolhassan Ghaderi
Mohammad Reza Hafezi Ahmadi
Ehsan Hosseini
Ali Akbar Movasaghpour Akbari
Abbas Ali Hosein Pour Feyzi
Ataollah Hiradfar
Majid Farshdousti Hagh
Publikationsdatum
01.01.2016
Verlag
Springer London
Erschienen in
Comparative Clinical Pathology / Ausgabe 1/2016
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-015-2156-2

Weitere Artikel der Ausgabe 1/2016

Comparative Clinical Pathology 1/2016 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …